Integral Health Asset Management
Latest statistics and disclosures from Integral Health Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INSM, THC, BSX, VERA, CYTK, and represent 28.71% of Integral Health Asset Management's stock portfolio.
- Added to shares of these 10 stocks: INSM (+$41M), CNC (+$30M), CAH (+$30M), VERA (+$28M), CVS (+$22M), NBIX (+$22M), LLY (+$22M), ISRG (+$21M), MCK (+$20M), GILD (+$19M).
- Started 33 new stock positions in SWTX, CNC, AZN, RGEN, ACHC, DYN, CMPS, ZNTL, WBA, OSCR.
- Reduced shares in these 10 stocks: Longboard Pharmaceuticals In (-$35M), , THC (-$16M), ACLX (-$13M), MDT (-$12M), INSP (-$11M), CLDX (-$10M), TFX (-$7.4M), CRSP (-$7.0M), APLT (-$6.8M).
- Sold out of its positions in APLT, CLDX, EVH, GEHC, NTLA, IQV, Longboard Pharmaceuticals In, MYGN, NGNE, NVS. RVTY, TNDM, TNGX, TFX, TNYA, TWST, VRDN, CRSP.
- Integral Health Asset Management was a net buyer of stock by $330M.
- Integral Health Asset Management has $1.2B in assets under management (AUM), dropping by 32.01%.
- Central Index Key (CIK): 0001773206
Tip: Access up to 7 years of quarterly data
Positions held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 81 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 12.1 | $142M | +41% | 2.1M | 69.04 |
|
| Tenet Healthcare Corp Com New (THC) | 4.3 | $51M | -24% | 400k | 126.23 |
|
| Boston Scientific Corporation (BSX) | 4.2 | $49M | 550k | 89.32 |
|
|
| Vera Therapeutics Cl A (VERA) | 4.1 | $49M | +130% | 1.2M | 42.29 |
|
| Cytokinetics Com New (CYTK) | 4.0 | $47M | +33% | 1.0M | 47.04 |
|
| Centene Corporation (CNC) | 2.6 | $30M | NEW | 500k | 60.58 |
|
| Cardinal Health (CAH) | 2.5 | $30M | NEW | 250k | 118.27 |
|
| Eli Lilly & Co. (LLY) | 2.5 | $29M | +280% | 38k | 772.00 |
|
| Encompass Health Corp (EHC) | 2.4 | $28M | +9% | 300k | 92.35 |
|
| Revolution Medicines (RVMD) | 2.1 | $24M | +57% | 550k | 43.74 |
|
| Blueprint Medicines (BPMC) | 2.0 | $24M | -5% | 275k | 87.22 |
|
| Edgewise Therapeutics Call Option (EWTX) | 1.9 | $23M | +70% | 850k | 26.70 |
|
| CVS Caremark Corporation (CVS) | 1.9 | $22M | NEW | 500k | 44.89 |
|
| Neurocrine Biosciences (NBIX) | 1.9 | $22M | NEW | 160k | 136.50 |
|
| Intuitive Surgical Com New (ISRG) | 1.8 | $21M | NEW | 40k | 521.96 |
|
| McKesson Corporation (MCK) | 1.7 | $20M | NEW | 35k | 569.91 |
|
| Merck & Co (MRK) | 1.7 | $20M | 200k | 99.48 |
|
|
| Bristol Myers Squibb (BMY) | 1.7 | $20M | +100% | 350k | 56.56 |
|
| Quest Diagnostics Incorporated (DGX) | 1.7 | $20M | +8% | 130k | 150.86 |
|
| Uniqure Nv SHS (QURE) | 1.7 | $19M | +175% | 1.1M | 17.66 |
|
| Tarsus Pharmaceuticals (TARS) | 1.7 | $19M | -6% | 350k | 55.37 |
|
| Inspire Med Sys (INSP) | 1.6 | $19M | -37% | 100k | 185.38 |
|
| Gilead Sciences (GILD) | 1.6 | $19M | NEW | 200k | 92.37 |
|
| Inari Medical Ord | 1.5 | $18M | -12% | 350k | 51.05 |
|
| Scholar Rock Hldg Corp (SRRK) | 1.4 | $16M | +36% | 375k | 43.22 |
|
| Brightspring Health Svcs (BTSG) | 1.4 | $16M | +90% | 950k | 17.03 |
|
| Crinetics Pharmaceuticals In (CRNX) | 1.3 | $15M | 300k | 51.13 |
|
|
| Astrazeneca Sponsored Adr (AZN) | 1.3 | $15M | NEW | 225k | 65.52 |
|
| Jasper Therapeutics Com New (JSPR) | 1.2 | $14M | +85% | 650k | 21.38 |
|
| Fresenius Medical Care Sponsored Adr (FMS) | 1.2 | $14M | +33% | 600k | 22.64 |
|
| Apellis Pharmaceuticals (APLS) | 1.1 | $13M | NEW | 420k | 31.91 |
|
| Medtronic SHS (MDT) | 1.0 | $12M | -50% | 150k | 79.88 |
|
| Acadia Healthcare (ACHC) | 1.0 | $12M | NEW | 300k | 39.65 |
|
| Dex (DXCM) | 1.0 | $12M | +25% | 150k | 77.77 |
|
| Biontech Se Sponsored Ads (BNTX) | 1.0 | $11M | +100% | 100k | 113.95 |
|
| Waters Corporation (WAT) | 0.9 | $11M | NEW | 30k | 370.98 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.9 | $11M | NEW | 500k | 22.04 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.9 | $11M | -9% | 200k | 54.15 |
|
| Mineralys Therapeutics (MLYS) | 0.9 | $11M | +145% | 875k | 12.31 |
|
| Janux Therapeutics (JANX) | 0.9 | $11M | NEW | 200k | 53.54 |
|
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $11M | +80% | 45k | 235.31 |
|
| Humana (HUM) | 0.9 | $10M | NEW | 40k | 253.71 |
|
| Oscar Health Cl A (OSCR) | 0.8 | $9.4M | NEW | 700k | 13.44 |
|
| Cooper Cos (COO) | 0.8 | $9.2M | -9% | 100k | 91.93 |
|
| Krystal Biotech (KRYS) | 0.7 | $8.6M | NEW | 55k | 156.66 |
|
| EXACT Sciences Corporation (EXAS) | 0.7 | $8.4M | +87% | 150k | 56.19 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $8.4M | NEW | 150k | 55.98 |
|
| 89bio (ETNB) | 0.7 | $7.8M | +100% | 1.0M | 7.82 |
|
| Arcellx Common Stock (ACLX) | 0.7 | $7.7M | -63% | 100k | 76.69 |
|
| Protara Therapeutics Com Stk (TARA) | 0.6 | $7.4M | NEW | 1.4M | 5.28 |
|
| Keros Therapeutics (KROS) | 0.6 | $7.1M | +125% | 450k | 15.83 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $7.0M | -29% | 900k | 7.73 |
|
| Quidel Corp (QDEL) | 0.6 | $6.7M | +20% | 150k | 44.55 |
|
| Catalyst Pharmaceutical Partners (CPRX) | 0.5 | $6.3M | -25% | 300k | 20.87 |
|
| Viking Therapeutics (VKTX) | 0.5 | $6.0M | -40% | 150k | 40.24 |
|
| Bruker Corporation (BRKR) | 0.5 | $5.9M | -25% | 100k | 58.62 |
|
| Repligen Corporation (RGEN) | 0.5 | $5.8M | NEW | 40k | 143.94 |
|
| Alignment Healthcare (ALHC) | 0.5 | $5.6M | NEW | 500k | 11.25 |
|
| Illumina (ILMN) | 0.5 | $5.3M | NEW | 40k | 133.63 |
|
| Insulet Corporation (PODD) | 0.4 | $5.2M | NEW | 20k | 261.07 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.4 | $5.2M | NEW | 275k | 18.80 |
|
| Nurix Therapeutics (NRIX) | 0.4 | $4.7M | +25% | 250k | 18.84 |
|
| Walgreen Boots Alliance (WBA) | 0.4 | $4.7M | NEW | 500k | 9.33 |
|
| Tg Therapeutics (TGTX) | 0.4 | $4.5M | NEW | 150k | 30.10 |
|
| Pliant Therapeutics (PLRX) | 0.3 | $4.0M | 300k | 13.17 |
|
|
| Springworks Therapeutics (SWTX) | 0.3 | $3.6M | NEW | 100k | 36.13 |
|
| Dyne Therapeutics (DYN) | 0.3 | $3.5M | NEW | 150k | 23.56 |
|
| Mereo Biopharma Group Spon Ads (MREO) | 0.3 | $3.5M | 1.0M | 3.50 |
|
|
| Sana Biotechnology (SANA) | 0.3 | $3.3M | +11% | 2.0M | 1.63 |
|
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $3.2M | NEW | 1.1M | 3.03 |
|
| Terns Pharmaceuticals (TERN) | 0.2 | $2.5M | +50% | 450k | 5.54 |
|
| Rezolute Com New (RZLT) | 0.2 | $2.5M | +100% | 500k | 4.90 |
|
| Staar Surgical Com Par $0.01 (STAA) | 0.2 | $2.4M | +100% | 100k | 24.29 |
|
| Travere Therapeutics (TVTX) | 0.1 | $1.7M | NEW | 100k | 17.42 |
|
| Silence Therapeutics Ads (SLN) | 0.1 | $1.4M | NEW | 200k | 6.88 |
|
| Atyr Pharma Com New (ATYR) | 0.1 | $1.4M | NEW | 375k | 3.62 |
|
| Kyverna Therapeutics (KYTX) | 0.1 | $1.3M | +75% | 350k | 3.74 |
|
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $1.3M | NEW | 300k | 4.23 |
|
| Cabaletta Bio (CABA) | 0.1 | $1.1M | +11% | 500k | 2.27 |
|
| Fate Therapeutics (FATE) | 0.1 | $990k | -38% | 600k | 1.65 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $756k | NEW | 200k | 3.78 |
|
Past Filings by Integral Health Asset Management
SEC 13F filings are viewable for Integral Health Asset Management going back to 2019
- Integral Health Asset Management 2024 Q4 filed Feb. 14, 2025
- Integral Health Asset Management 2024 Q3 filed Nov. 14, 2024
- Integral Health Asset Management 2024 Q2 filed Aug. 14, 2024
- Integral Health Asset Management 2024 Q1 filed May 15, 2024
- Integral Health Asset Management 2023 Q3 filed Nov. 14, 2023
- Integral Health Asset Management 2023 Q2 filed Aug. 11, 2023
- Integral Health Asset Management 2023 Q1 filed May 9, 2023
- Integral Health Asset Management 2022 Q4 filed Feb. 13, 2023
- Integral Health Asset Management 2022 Q3 filed Nov. 14, 2022
- Integral Health Asset Management 2022 Q2 filed Aug. 3, 2022
- Integral Health Asset Management 2022 Q1 filed May 12, 2022
- Integral Health Asset Management 2021 Q4 filed Feb. 2, 2022
- Integral Health Asset Management 2021 Q3 filed Nov. 12, 2021
- Integral Health Asset Management 2021 Q2 restated filed Aug. 30, 2021
- Integral Health Asset Management 2021 Q2 filed Aug. 13, 2021
- Integral Health Asset Management 2021 Q1 filed May 10, 2021